These inherent limitations of cancer cell line – based models also restricted our ability to evaluate the oncogenic activities of endogenous KRAS4A, as the low abundance of KRAS4A transcripts in these cells was insufficient to reveal clear phenotypic changes upon depletion. This evidence concerns the gene KRAS and cancer.